Chemoinformaics analysis of Thalifendine chloride
| Molecular Weight | 357.793 | nRot | 1 |
| Heavy Atom Molecular Weight | 341.665 | nRig | 25 |
| Exact Molecular Weight | 357.077 | nRing | 5 |
| Solubility: LogS | -6.571 | nHRing | 3 |
| Solubility: LogP | 4.154 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 48.8867 |
| nHD | 1 | BPOL | 22.9693 |
| QED | 0.7 |
| Synth | 2.923 |
| Natural Product Likeliness | 1.683 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.999 |
| HIA | 0.004 |
| CACO-2 | -5.152 |
| MDCK | 0.0000235 |
| BBB | 0.594 |
| PPB | 0.959296 |
| VDSS | 0.959 |
| FU | 0.0282284 |
| CYP1A2-inh | 0.942 |
| CYP1A2-sub | 0.729 |
| CYP2c19-inh | 0.052 |
| CYP2c19-sub | 0.364 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.585 |
| CYP2d6-inh | 0.951 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.261 |
| CYP3a4-sub | 0.22 |
| CL | 14.725 |
| T12 | 0.289 |
| hERG | 0.165 |
| Ames | 0.436 |
| ROA | 0.13 |
| SkinSen | 0.931 |
| Carcinogencity | 0.908 |
| EI | 0.113 |
| Respiratory | 0.91 |
| NR-Aromatase | 0.713 |
| Antiviral | Yes |
| Prediction | 0.671808 |